Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition

• Lorenz Thurner,
• Moritz Bewarder,
• Florian Rosar,
• Patrick Orth,
• Raoul Boris Meuter,
• Torben Rixecker,
• Vadim Lesan,
• Dieter Michael Kohn,
• Günther Schneider,
• Daniel Baumhoer,
• Rainer Maria Bohle,
• Christian Veith,
• Joerg Thomas Bittenbring

Affiliations

Lorenz Thurner

1 José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany

Moritz Bewarder

1 José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany

Florian Rosar

2 Institute of Nuclear Medicine, Saarland University Medical School, Homburg, Germany

Patrick Orth

3 Department of Orthopedics, Saarland University Medical School, Homburg, Germany

Raoul Boris Meuter

4 Hopitaux Robert Schuman, Chimiothérapie, Oncologie, Hématologie, Luxembourg

Torben Rixecker

1 José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany

Vadim Lesan

1 José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany

Dieter Michael Kohn

3 Department of Orthopedics, Saarland University Medical School, Homburg, Germany

Günther Schneider

5 Department of Radiology, Saarland University Medical School, Homburg, Germany

Daniel Baumhoer

6 Bone Tumor Reference Center at the Institute for Medical Genetics and Pathology, University Hospital Basel, University of Basel, Switzerland

Rainer Maria Bohle

7 Institute of Pathology, Saarland University Medical School, Homburg, Germany.

Christian Veith

7 Institute of Pathology, Saarland University Medical School, Homburg, Germany.

Joerg Thomas Bittenbring

1 José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany